arrow
P

Philippe Mathurin

hopital universitaire saint-antoine - aphp
H指数:101
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Management of severe acute alcoholic hepatitis in France: results of a national survey: R1

法国严重急性酒精性肝炎的管理:一项全国性调查的结果:R1

2026-06-010
PRE
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program

REP 2139-Mg在HDV相关晚期肝病患者的国际同情用药项目中的安全性与有效性

2025-11-060
PRE
Alcohol-related hepatitis induces a specific fibrosis profile through YAP activation in myofibroblasts

酒精性肝炎通过激活肌成纤维细胞中的YAP诱导特定的纤维化表型。

2025-08-290
OAAI
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease

靶向抑制致病共生菌毒力因子可缓解酒精性肝病

2025-05-280
PRE
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis

非侵入性检测动态在指导肝硬化患者HCV治愈后HCC监测决策中的价值

2025-02-260
PRE
Resolution of Metabolic Dysfunction-associated Steatohepatitis With No Worsening of Fibrosis After Bariatric Surgery Improves 15-year Survival: A Prospective Cohort Study

代谢功能障碍相关脂肪性肝炎的代谢紊乱改善且纤维化无加重后,减重手术可提高15年生存率:一项前瞻性队列研究

2024-12-190
PRE
Viral antibody response predicts morbidity and mortality in alcohol-associated hepatitis
2024-09-250
PRE
Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide
2024-08-012
OAAI
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort
2024-08-012
OAAI
Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis
2024-02-201
PRE
Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis: Systematic review and meta-analysis
2024-02-018
OA
Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD
2024-01-012
OAAI
Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study
OBESITY
IF4.7
2023-11-216
OAAI
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis
2023-11-0136
OAAI
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming

酒精相关性肝病中的肝细胞去分化分析将CXCR4鉴定为细胞重编程的驱动因素

2023-09-0111
OAAI